Does APIXABAN Cause Haematocrit decreased? 171 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 171 reports of Haematocrit decreased have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
171
Reports of Haematocrit decreased with APIXABAN
0.1%
of all APIXABAN reports
4
Deaths
109
Hospitalizations
How Dangerous Is Haematocrit decreased From APIXABAN?
Of the 171 reports, 4 (2.3%) resulted in death, 109 (63.7%) required hospitalization, and 13 (7.6%) were considered life-threatening.
Is Haematocrit decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 171 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Haematocrit decreased?
CLOZAPINE (1,027)
RUXOLITINIB (562)
ECULIZUMAB (466)
ADALIMUMAB (455)
NIRAPARIB (406)
METHOTREXATE (396)
PALBOCICLIB (357)
RITUXIMAB (328)
ALEMTUZUMAB (283)
PREDNISONE (283)
Which APIXABAN Alternatives Have Lower Haematocrit decreased Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ